cartesian therapeutics logo

Cartesian Therapeutics, Inc.

Cartesian Therapeutics is a biotechnology company developing novel cellular immunotherapies to cure cancer. The companys lead product, Descartes-08, is a novel chimeric antigen receptor (CAR) _ based cell therapy to cure multiple myeloma.

Cartesian Therapeutics proprietary technology was developed by researchers at the National Institutes of Health (NIH).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.cartesiantherapeutics.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
12111 Parklawn Dr, Suite 245 MD 20852
Rockville
United States
Email
Contact Number
+1 301 348 8698

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/cartesian-therapeutics” connections=”true” suffix=””]

Cartesians pipeline consists of multiple safety-profiled chimeric antigen receptor cell therapy products for treatment of multiple myeloma and other diseases.

Key investor in Cartesian Therapeutics includes, Schooner Capital a Boston-based private investment firm.